Knockdown of IGFBP5 in the uteri of PCOS-like mice abolished the beneficial effects of IL-22, whereas IGFBP5 supplementation restored endometrial receptivity and rescued implantation. The gene discussed is IGFBP5; the disease is polycystic ovary syndrome.